Clinical Trials Logo

Syndrome clinical trials

View clinical trials related to Syndrome.

Filter by:

NCT ID: NCT06407687 Not yet recruiting - Clinical trials for Quadratus Lumborum Syndrome

Compare Electrodry Needlig and Dry Needling in Mechanical Low Back Pain

Start date: June 2024
Phase: N/A
Study type: Interventional

Mechanical low back pain (LBP) generally results from an acute traumatic event, but it may also be caused by cumulative trauma. The severity of an acute traumatic event varies widely, from twisting one's back to being involved in a motor vehicle collision. Mechanical LBP due to cumulative trauma tends to occur more commonly in the workplace and Quadratus Lumborum injury plays an important role in causing MLBP. The aim of this study is To compare the effects of Electrical Dry Needling and Dry Needling on pain, endurance and range of motion in patients with Quadratus Lumborum Syndrome.

NCT ID: NCT06407414 Recruiting - Clinical trials for Patellofemoral Pain Syndrome

Effectiveness of Neuromuscular Exercise in Patellofemoral Pain Syndrome

Start date: May 14, 2024
Phase: N/A
Study type: Interventional

The aim of the study is to investigate the effects of a neuromuscular exercise program on strength, balance, sleep quality and functionality in individuals with Patellofemoral pain syndrome.

NCT ID: NCT06406933 Recruiting - Dry Eye Syndromes Clinical Trials

Salivary Conductivity Screening for Primary Sjögren's Syndrome

Start date: July 1, 2023
Phase:
Study type: Observational

Dry eye disease, or keratoconjunctivitis sicca, is one of the most common diseases encountered at ophthalmologic clinics. Patient with dry eye disease commonly presented foreign body sensation, red eye, blurred vision, etc. Numerous treatments for dry eye disease are proposed due to its multifactorial etiology. Sjögren syndrome, which is one of the main etiologies of dry eye disease, is an autoimmune disease characterized by dysfunction of lacrimal and salivary glands. Although dry eye status can be easily examined by ocular surface staining, the methods quantifying salivary flow rate are hard to performed clinically, such as salivary gland scintigraphy and sialometry. Furthermore, disease activity could only rely on serum markers or salivary gland ultrasound. Recently, a portable device measuring salivary conductivity is believed to assess fluid status and renal function. Interestingly, the composition of salivary electrolytes in patients with Sjögren syndrome is different from those with other causes of hyposalivation. Thus, this study aims to evaluate whether salivary conductivity in combination with ocular surface staining can be a non-invasive diagnostic test for primary Sjögren syndrome among people with dry eye disease.

NCT ID: NCT06406023 Recruiting - Piriformis Syndrome Clinical Trials

Effectiveness of Instrument Assisted Soft Tissue Mobilization in Management of Piriformis Syndrome

Start date: January 10, 2024
Phase: N/A
Study type: Interventional

This study aims to assess the effectiveness of IASTM on pain, ROM, Disability and Quality of life among Piriformis Syndrome patients. This study will add to the growing body of knowledge as there are very limited researches done in Pakistan using IASTM in patients with Piriformis Syndrome.

NCT ID: NCT06405438 Not yet recruiting - Clinical trials for Carpal Tunnel Syndrome

Comparison of the Efficacy of Peloid Therapy and Paraffin Treatment in Carpal Tunnel Syndrome

Start date: June 1, 2024
Phase: N/A
Study type: Interventional

This study compares the effectiveness of peloid therapy and paraffin treatment in carpal tunnel syndrome. Patients receive either 2 weeks of peloid therapy or 15 sessions of paraffin treatment, along with splint therapy for 3 months. Pain and symptom severity are assessed using the Visual Analog Scale (VAS) and Boston Carpal Tunnel Syndrome Questionnaire (BCTQ). Results are measured at baseline, 4 weeks post-treatment, and a 12-week follow-up.

NCT ID: NCT06405243 Not yet recruiting - Clinical trials for Polycystic Ovary Syndrome

Myoinositol, L-arginine and Chromium With Letrozole for Ovulation Induction in Polycystic Ovarian Syndrome Patients

Start date: June 30, 2024
Phase: Phase 3
Study type: Interventional

The aim of the study is to compare and assess the efficacy of combined letrozole with myoinositol, chromium, or L-arginine in infertile women with PCOS. This study will help in the investigation of alternative therapeutic modalities for fertility improvement in polycystic ovarian syndrome

NCT ID: NCT06405152 Recruiting - Clinical trials for Macrophage Activation Syndrome

Assessment of Macrophage Activation syndromE in STill's Disease

AMETHYST
Start date: September 27, 2023
Phase:
Study type: Observational

Assessment of Macrophage activation syndrome in STill's disease: retrospective chart analysis of patient History, Symptom resolution and Treatment characteristics

NCT ID: NCT06401811 Recruiting - Sjogren's Syndrome Clinical Trials

Reliability, Validity, and Responsiveness of the Turkish Version of Eating Assessment Tool-10 for Patients With Primer Sjögren's Syndrome

Start date: June 4, 2024
Phase:
Study type: Observational [Patient Registry]

Evaluations will be made by researchers following the guidance of individuals with primary Sjögren's Syndrome who receive diagnosis, routine medical care, and treatment management. In addition, for the reliability of the Turkish Eating Assessment Tool-10, the Turkish Eating Assessment Tool-10 will be repeated on patients at least one-fifth of the number of individuals included, after one week. For the sensitivity of the scale, an exercise that is routinely applied in the Rheumatological Rehabilitation Unit of Hacettepe University Faculty of Physical Therapy and Rehabilitation will be invited and after 3 months, the same evaluations as applied in the first measurement will be made again on individuals at least one-fifth of the number of individuals included.

NCT ID: NCT06401538 Not yet recruiting - Jeavons Syndrome Clinical Trials

BMB-101 in Epilepsy With Eyelid Myoclonia (EEM)

Start date: July 15, 2024
Phase: Phase 2
Study type: Interventional

The study is a pilot, open-label, study to test whether BMB-101 is safe and effective in reducing the frequency of seizures in subjects with Epilepsy with Eyelid Myoclonia (also called Jeavons Syndrome). The study will last up to 6 months. There will be a 1 month screening period, then 3 months on open-label BMB-101 including titration and tapering/washout periods, and then a 1 month follow-up period. There will be 7 clinic visits.

NCT ID: NCT06400433 Not yet recruiting - Clinical trials for Carpal Tunnel Syndrome

Comparing Efficacies of Median Nerve Hydrodissection With Dexamethasone and Dextrose in Carpal Tunnel Syndrome

Start date: May 13, 2024
Phase: N/A
Study type: Interventional

The aim of this study is to compare the efficacy of ultrasonography-guided hydrodissection technique with 5% dextrose and dexamethasone injectates when applied in different volumes in the treatment of mild to moderate carpal tunnel syndrome.